Radiant Biotherapeutics, a Canadian biotech advancing multi-specific, multi-affinity antibody (Multabody) therapeutics in ...

Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...

The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...

Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies announced the formalization of ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...

Japan’s JCR Pharmaceuticals (TYO: 4552) closed 15% higher after Wednesday’s trading, as it signed a new licensing deal.

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...